UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability Journal article
International Journal of Nanomedicine, 2017,Volume: 12,Page: 4147-4162
Authors:  Gao F.;  Zhang J.;  Fu C.;  Xie X.;  Peng F.;  You J.;  Tang H.;  Wang Z.;  Li P.;  Chen J.
Favorite  |  View/Download:7/0  |  Submit date:2018/12/28
Breast cancer  IRGD  Isoliquiritigenin  Lipid–polymer hybrid NPs  
Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells Journal article
SCIENTIFIC REPORTS, 2017,Volume: 7
Authors:  Zhang, Jinming;  Wang, Lu;  Chan, Hon Fai;  Xie, Wei;  Chen, Sheng;  He, Chengwei;  Wang, Yitao;  Chen, Meiwan
View  |  Adobe PDF(1919Kb)  |  Favorite  |  View/Download:378/11  |  Submit date:2018/10/30
iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability Journal article
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017,Volume: 12,Page: 4147-4162
Authors:  Gao, Fei;  Zhang, Jinming;  Fu, Chaomei;  Xie, Xiaoming;  Peng, Fu;  You, Jieshu;  Tang, Hailin;  Wang, Zhiyu;  Li, Peng;  Chen, Jianping
Favorite  |  View/Download:18/0  |  Submit date:2018/10/30
isoliquiritigenin  iRGD  lipid-polymer hybrid NPs  breast cancer  
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy Journal article
Nanomedicine: Nanotechnology, Biology, and Medicine, 2016,Volume: 12,Issue: 5,Page: 1303
Authors:  Zhang J.;  Hu J.;  Chan H.F.;  Skibba M.;  Liang G.;  Chen M.
Favorite  |  View/Download:10/0  |  Submit date:2018/10/30
Active Targeting  Doxorubicin  Hepatocellular Carcinoma  Irgd Peptide  Sorafenib